Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;17(Suppl 1):S302-S304.
doi: 10.4103/jpbs.jpbs_1954_24. Epub 2025 Apr 29.

Determining Breast Density in Patients with Metabolic Syndrome: A Cross Sectional Study

Hamta Taheri Sarvetamin  1
Affiliations

Determining Breast Density in Patients with Metabolic Syndrome: A Cross Sectional Study

Hamta Taheri Sarvetamin. J Pharm Bioallied Sci. 2025 May.

Abstract

Introduction and objective: Breast density is considered a primary factor of mammography sensitivity, which serves as an optimal tool for breast cancer screening, given the potential role of metabolic syndrome in increasing breast density. Therefore, this study aimed to determine breast density in patients with this syndrome.

Methods and methodology: This cross-sectional study was conducted on 196 premenopausal women divided into metabolic syndrome and healthy groups. Mammograms were performed, and breast density was measured based on the ACR standard definition. The collected data were analyzed using the Chi-square test and SPSS software version 18.

Findings: In the control group, 24% were classified as A, 28% as B, 24% as C, and 24% as D. In the experimental group, 20.8% were classified as A, 8.3% as B, 41.7% as C, and 29.2% as D (P value = 0.001). There was no significant difference between the frequency of lesions requiring further evaluation and benign lesions (P value > 0.05).

Conclusion: Based on the results, metabolic syndrome may increase mammographic density.

Keywords: ACR standard definition; breast cancer; breast density; mammography.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Samardar P, de Paredes ES, Grimes MM, Wilson JD. Focal asymmetric densities seen at mammography: US and pathologic correlation. Radiographics. 2002;22:19–33. - PubMed
    1. Akbari ME, Khayamzadeh M, Khoshnevis S, Nafisi N, Akbari A. Five and ten years survival in breast cancer patients mastectomies vs. breast conserving surgeries personal experience. Iran J Cancer Prev. 2012;1:53–6.
    1. Kopans D. Breast imaging. 3rd edn. London, UK: Lippincott Williams & Wilkins; 2007.
    1. Shetty MK, Watson AB. Sonographic evaluation of the focal asymmetric density of the breast. Ultrasound Q. 2002;18:115–21. - PubMed
    1. Bergh J, Wiklund T, Erikstein B, Lidbrink E, Lindman H, Malmström P, et al. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: A randomized trial. Lancet. 2000;356:1384–91. - PubMed

LinkOut - more resources